Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-000599

Chief Executive Officer acquired 892,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nolan Sean P. Chief Executive Officer 2025-01-02 Grant or award +892,500 2,078,358 D
Derivatives
Nolan Sean P. Chief Executive Officer 2025-01-02 Grant or award · Employee Stock Option (right to buy) +892,500 892,500 D
Loading xslF345X05/form4-01032025_100137.xml…